Phase II study of lenvatinib in patients with differentiated, medullary, and anaplastic thyroid cancer: Final analysis results.-Reference-Cited by-同舟云学术

Phase II study of lenvatinib in patients with differentiated, medullary, and anaplastic thyroid cancer: Final analysis results.

Published:2016-05-20 Issue:15_suppl Volume:34 Page:6088-6088
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Takahashi Shunji¹,Kiyota Naomi²,Yamazaki Tomoko³,Chayahara Naoko²,Nakano Kenji¹,INAGAKI LINA¹,Toda Kazuhisa⁴,Enokida Tomohiro³,Minami Hironobu²,Imamura Yoshinori²,Sasaki Tatsuya⁵,Suzuki Takuya⁵,Fujino Katsuki⁵,Dutcus Corina⁶,Tahara Makoto³

Affiliation:

1. Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan;

2. Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan;

3. Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan;

4. Department of Head and Neck Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan;

5. Eisai Co. Ltd., Tokyo, Japan;

6. Eisai Inc., Woodcliff Lake, NJ;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.6088

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of anaplastic thyroid carcinoma suffering from tracheoesophageal fistula and wound healing disorder of the gastrostomy site during lenvatinib therapy;JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY;2024

2. Outcomes of Sorafenib or Lenvatinib Therapy for Differentiated Thyroid Carcinoma;Practica oto-rhino-laryngologica. Suppl.;2023

3. Clinical analysis of lenvatinib therapy for unresectable thyroid cancer at Nagoya City University Hospital and related facilities;Toukeibu Gan;2022

4. Management of VEGFR-Targeted TKI for Thyroid Cancer;Cancers;2021-11-04

5. Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities;International Journal of Molecular Sciences;2021-03-18